Elizabeth L R Barry

Summary

Affiliation: Dartmouth Medical School
Country: USA

Publications

  1. pmc CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment
    Elizabeth L Barry
    Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
    Cancer Causes Control 24:47-54. 2013
  2. ncbi request reprint K-ras mutations in incident sporadic colorectal adenomas
    Elizabeth L R Barry
    Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03766, USA
    Cancer 106:1036-40. 2006
  3. ncbi request reprint Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention
    Elizabeth L R Barry
    Department of Community and Family Medicine, Dartmouth Medical School, 46 Centerra Parkway, Ste 300, Lebanon, NH 03766, USA
    J Natl Cancer Inst 98:1494-500. 2006
  4. pmc Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial
    Elizabeth L Barry
    Department of Community and Family Medicine, Dartmouth Medical School, Suite 300, Evergreen Center, 46 Centerra Parkway, Lebanon, NH 03756, USA
    Cancer Epidemiol Biomarkers Prev 18:2726-33. 2009
  5. pmc Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention
    Elizabeth L Barry
    Department of Community and Family Medicine, Dartmouth Medical School, 46 Centerra Parkway, Suite 300, Lebanon, NH 03766, USA
    Cancer Prev Res (Phila) 4:2072-82. 2011

Detail Information

Publications5

  1. pmc CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment
    Elizabeth L Barry
    Geisel School of Medicine at Dartmouth, Lebanon, NH, USA
    Cancer Causes Control 24:47-54. 2013
    ..Two common nonsynonymous polymorphisms in CYP2C9 are associated with reduced enzyme activity: CYP2C9*2 (rs1799853, R144C) and CYP2C9*3 (rs1057910, I359L)...
  2. ncbi request reprint K-ras mutations in incident sporadic colorectal adenomas
    Elizabeth L R Barry
    Department of Community and Family Medicine, Dartmouth Medical School, Lebanon, New Hampshire 03766, USA
    Cancer 106:1036-40. 2006
    ..In the current study, the authors investigated associations with K-ras mutation in incident sporadic colorectal adenomas that occurred during a chemoprevention trial of calcium supplementation...
  3. ncbi request reprint Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention
    Elizabeth L R Barry
    Department of Community and Family Medicine, Dartmouth Medical School, 46 Centerra Parkway, Ste 300, Lebanon, NH 03766, USA
    J Natl Cancer Inst 98:1494-500. 2006
    ..Previous research suggests that the G315A single-nucleotide polymorphism in the ornithine decarboxylase (ODC) gene may be a genetic marker for risk of colorectal neoplasia and may also modify the association of aspirin use with risk...
  4. pmc Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial
    Elizabeth L Barry
    Department of Community and Family Medicine, Dartmouth Medical School, Suite 300, Evergreen Center, 46 Centerra Parkway, Lebanon, NH 03756, USA
    Cancer Epidemiol Biomarkers Prev 18:2726-33. 2009
    ..These results support the hypothesis that COX-2 plays a role in the etiology of colon cancer and may be a target for aspirin chemoprevention and warrant further investigation in other colorectal adenoma and cancer populations...
  5. pmc Variants downstream of the ornithine decarboxylase gene influence risk of colorectal adenoma and aspirin chemoprevention
    Elizabeth L Barry
    Department of Community and Family Medicine, Dartmouth Medical School, 46 Centerra Parkway, Suite 300, Lebanon, NH 03766, USA
    Cancer Prev Res (Phila) 4:2072-82. 2011
    ..Our findings suggest that common genetic variants located downstream (3') of the ODC gene influence risk of colorectal adenoma and may also impact the efficacy of aspirin chemoprevention...